International Patent: MOLECULAR MARKER FOR EARLY SCREENING OF RENAL FIBROSIS AND USE THEREOF

GENEVA, Aug. 14 -- SHANGHAI EAST HOSPITAL (EAST HOSPITAL, TONGJI UNIVERSITY SCHOOL OF MEDICINE) filed a patent application (CN2025/089588) for “MOLECULAR MARKER FOR EARLY SCREENING OF RENAL FIBROSIS AND USE THEREOF”. With publication no. WO/2026/166006, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12Q 1/68

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....